申请人:Eli Lilly and Company
公开号:US05874427A1
公开(公告)日:1999-02-23
This invention provides novel 5-HT.sub.1F agonists of the Formula ##STR1## in which X, Y, E, R, A, B, and n are as defined in the specification, which are useful for the treatment of migraine and associated disorders.
这项发明提供了新颖的5-HT.sub.1F激动剂,其化学式为##STR1##其中X、Y、E、R、A、B和n如规范中定义,对治疗偏头痛及相关疾病有用。